Ad is loading...
NCNA
Price
$1.33
Change
+$0.11 (+9.02%)
Updated
Dec 6, 04:59 PM (EDT)
RNAC
Price
$25.00
Change
+$1.99 (+8.65%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

NCNA vs RNAC

Header iconNCNA vs RNAC Comparison
Open Charts NCNA vs RNACBanner chart's image
NuCana
Price$1.33
Change+$0.11 (+9.02%)
Volume$496
CapitalizationN/A
Cartesian Therapeutics
Price$25.00
Change+$1.99 (+8.65%)
Volume$114
CapitalizationN/A
NCNA vs RNAC Comparison Chart
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NCNA vs. RNAC commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCNA is a Buy and RNAC is a Buy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (NCNA: $1.34 vs. RNAC: $25.14)
Brand notoriety: NCNA and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NCNA: 82% vs. RNAC: 113%
Market capitalization -- NCNA: $4.87M vs. RNAC: $584.8M
NCNA [@Biotechnology] is valued at $4.87M. RNAC’s [@Biotechnology] market capitalization is $584.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NCNA’s FA Score shows that 1 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • NCNA’s FA Score: 1 green, 4 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 5 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • NCNA’s TA Score: 5 bullish, 2 bearish.
  • RNAC’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, NCNA is a better buy in the short-term than RNAC.

Price Growth

NCNA (@Biotechnology) experienced а +3.08% price change this week, while RNAC (@Biotechnology) price change was +33.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

NCNA is expected to report earnings on Aug 14, 2024.

RNAC is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($585M) has a higher market cap than NCNA($4.87M). RNAC YTD gains are higher at: 21.555 vs. NCNA (-81.880). NCNA has higher annual earnings (EBITDA): -33.04M vs. RNAC (-262.89M). RNAC has more cash in the bank: 219M vs. NCNA (11.6M). NCNA has less debt than RNAC: NCNA (281K) vs RNAC (14.7M). RNAC has higher revenues than NCNA: RNAC (47.9M) vs NCNA (0).
NCNARNACNCNA / RNAC
Capitalization4.87M585M1%
EBITDA-33.04M-262.89M13%
Gain YTD-81.88021.555-380%
P/E RatioN/AN/A-
Revenue047.9M-
Total Cash11.6M219M5%
Total Debt281K14.7M2%
FUNDAMENTALS RATINGS
NCNA vs RNAC: Fundamental Ratings
NCNA
RNAC
OUTLOOK RATING
1..100
1432
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9439
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
4675

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (16) in the Biotechnology industry is significantly better than the same rating for RNAC (99). This means that NCNA’s stock grew significantly faster than RNAC’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that NCNA’s stock grew similarly to RNAC’s over the last 12 months.

NCNA's SMR Rating (99) in the Biotechnology industry is in the same range as RNAC (100). This means that NCNA’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for NCNA (94). This means that RNAC’s stock grew somewhat faster than NCNA’s over the last 12 months.

RNAC's P/E Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for NCNA (100). This means that RNAC’s stock grew somewhat faster than NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NCNARNAC
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYAX38.270.38
+1.00%
American Beacon Man Lg Cp Growth A
KTCIX51.700.34
+0.66%
DWS Science and Technology Inst
BISAX19.180.06
+0.31%
Brandes International Small Cap Equity A
YOVIX17.170.04
+0.23%
Yorktown Small-Cap Institutional
LBRIX32.89-0.03
-0.09%
ClearBridge Dividend Strategy FI

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+9.84%
RNAC - NCNA
93%
Closely correlated
+9.26%
AGEN - NCNA
93%
Closely correlated
+14.01%
SNPX - NCNA
92%
Closely correlated
-4.05%
ALLR - NCNA
86%
Closely correlated
+1.85%
NRXP - NCNA
85%
Closely correlated
+2.52%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+9.26%
SNPX - RNAC
91%
Closely correlated
-4.05%
ALLR - RNAC
86%
Closely correlated
+1.85%
NRXP - RNAC
86%
Closely correlated
+2.52%
PALI - RNAC
81%
Closely correlated
+1.14%
BTAI - RNAC
35%
Loosely correlated
+6.75%
More